| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |